Effect of cholesterol biosynthesis inhibitor on some biochemical parameters in normal male rats

Iraqi Journal of Veterinary Sciences

Volumn 23, Issue 1, 2009, Pages 5-12

  Kalo, M S ^a  

^a UNIVERSITY OF MOSUL   (Iraq)

Author keywords

Cholesterol; Rats; Simvastatin; Testosterone

Indexed keywords

RATTUS; RATTUS NORVEGICUS;

EID: 73449149030     PISSN: 16073894     EISSN: 20711255     Source Type: Journal    
DOI: 10.33899/ijvs.2009.5684     Document Type: Article

References (47)

1. Martin G, Pilon A, Albert C, Valle M, Hum DW, Fruchart JC, Najib J, Clarey V, Stael B. Comparison of expression and regulation of the high- density lipoprotein receptor SR-BI and the low- density lipoprotein receptor in human adrenocortical carcinoma NCI- H295 cells. Eur J Biochem.1999; 261: 481-491.
2. nd ed. Prentice- Hall Inc.; 1996. 488-490 p.
3. th ed. McGraw-Hill Company; 2006. 446 p.
4. King MW. Medical biochemistry. Indiana: Academic Excellece; 2004. 190 p.
5. Robins ED, Nelson LM, Hoeg JM. Aberrant hypothalamic- pituitary-ovarian axis in the Watanabe heritable hyperlipidemic rabbits. J Lipid Res. 1994; 35(1): 52-59.
6. Banaszewska B, Pawelezyk L, Spaczynski RZ, Dziura J, Duleba AJ. Effect of simvastatin and oral contraceptive agent on polycystic ovary syndrome: Prospective, randomized, Crossover trial. Journal of Clinical Endocrinology and metabolism. 2007; 92(2): 456-461.
7. Azzarito c, Boiardi L, Vergoni W, Zini M, Portioli I. Testicular function in hypercholesterolemic male patients during prolonged simvastatin treatment. Horm Metab Res. 1996; 28(4): 193-198.
8. Shalaby MA, el-Zorba HY, Kamel GM. Effect of alpha tocopherol and simvastatin on male fertility in hypercholesterolemic rats. Pharmacol Res. 2004; 50(2): 137-142.
9. Elkin RG, Yan Z. Relationship between the inhibition of mevalonate biosynthesis and reduced fertility in laying hens. J Reprod Fertil. 1999; 116(2): 269-275.
10. Travia D, Tosi f, Negri C, Faccini G, Moghetti P, Muggeo M. Sustained therapy with 3- hydroxy 3- methyl glutaryl- coenzyme A reductase inhibitors does not impair steroidogenesis by adrenal and gonads. J Clin Endocrinol Metab. 1995; 80: 836-840.
11. Dobs AS, Miller S, Neri G, Weiss S, Tate AC, Shapiro DR, Musliner TA. Effect of simvastatin and pravastatin on gonadal function in male hypercholesterolemic patients. Metabolism. 2000; 49: 115-121.
12. Adah F, Benghuzzi H, Tucci M, Russell G, Tsao A, Olivier J, England B. Evaluation of the male reproductive organs after treatment with continuous sustained delivary of statin for fracture healing. Biomed Sci Instrum. 2005; 41: 54-61.
13. Kocum TH, Ozcan TI, Gen R, Tekin A, Erol T, Akcay B, Doven O. Does atrovastatin affect androgen levels in men in the era of very-low LDL targeting therapy?. Exp Clin Endocrinol Diabetes. 2008; Epub ahead of print.
14. Dostal LA, Whitfield LR, Anderson JA. Fertility and general reproduction studies in rats with the HMG- CoA reductase inhibitor, atrovastatin. Fundam Appl Toxicol. 1996; 32(2): 285-292.
15. Hall SA, Page ST, Travison TG, Montgomery RB, Link CL, McKinlay JB. Do statins affect androgen levels in men? Results from the Boston area community health survey. Cancer Epidemiol Biomarkers Prev. 2007; 16(8): 1587-1594.
16. American nutrient research council. National requirements of laboratory animals. Washington DC.: National Academy of Sciences; 1978. 7-27 p.
17. Tietz NW. Fundamentals of clinical chemistry. W. B. Saunders Company; 1985.
18. Timm K. Orbital venous anatomy of the rat. Lab Animals Sci. 1979; 2: 663-670.
19. Miyazawa T, Yasuda K, Fujumoto K. Chemiluminescence- high performance liquid chromatography of phosphatidyl cholin hydroperoxide. Anal Lett. 1987; 20: 915-925.
20. Morita T, Oh-hashi A, Takei K, Ikai M, Kasaoka S, Kiniyama Sh. Cholesterol- lowering effects of soybean, potato and rice protein depend on their low methionine contents in rats fed a cholesterol- free purified diet. J Nutr. 1997; 127(3): 470-477.
21. nd ed. New York: Mc- Graw Hill Book Company; 1980.
22. Duncan DB. Multiple range and multiple F test. Biometric. 1955; 11: 1-42.
23. Adah F, Benghuzzi H, Tucci M, Russell G, England B. Effects of sustained release of statin by means of tricalcium phosphate lysine delivery system in defect and segmental femoral injuries on certain biochemical markers in vivo. Biomed Sci Instrum. 2006; 42: 126-135.
24. Ormiston T, Wolkwitz OM, Reus VI, Johnson R, Manfredi F. Hormonal changes with cholesterol reduction: a double blind pilot study. J Clin Pharm Ther. 2004; 29(1): 71-73.
25. Friberg PA, Larsson DG, Rung E, Billig H. Apoptotic effects of a progesterone receptor antagonist on rat granulosa cells are not mediated via reduced protein isoprenylation. Mol Reprod Dev. 2007; 74(10):1317-1326.
26. Mathai D, Fidge N, Tozoka M, Mitchell A. Regulation of hepatic high density lipoprotein binding proteins after administration of simvastatin and cholestyramine to rats. Arteriosclerosis. 1990; 10(6): 1045-1050.
27. Bernini GP, Brogi G, Argenio GF, Moretti A, Salvetti A. Effects of long- term pravastatin treatment on spermatogenesis and on adrenal and steroidal steroidogenesis in male hypercholesterolemic patients. J Endocrinol Invest. 1998; 21(5): 310-317.
28. Kenis I, Tartakover-Matalon S, Cherepnin N, Drucker L, Fishman A, Pomeranz M, Lishner M. Simvastatin has deleterious effects on human first trimester placental explants. Hum Reprod. 2005; 20(10): 2866-2872.
29. Kong WJ, Wei J, Zuo ZY, Wang YM, Song DQ, You XF, Zhao LX, Pan HN, Jiang JD. Combination of simvastatin with berberine improves the lipid- lowering efficacy. Metabolism, 2008; 57(8): 1029-1037.
30. Kostner GM, Gavish D, Leopold B, Bolzano K, Weintraub MS, Breslow JL. HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels. Circulation. 1989; 80(5):1313-1319.
31. Benhizia F, Lagrange D, Malewiak MI, Griglio S. In vivo regulation of hepatic lipase activity and mRNA levels by diets which modify cholesterol influx to the liver. Biochim Biophys Acta. 1994; 1211(2): 181-188.
32. Kolovou GD, Mikhailidis DP, Daskalova DC, Kafaltis N, Adamopoulou EN, Malakos J, Bilianou HG, Theocharis SE, Pilatis ND, Mykoniatis MG, Cokkinos DV. The effect of co-administration of simvastatin and alcohol in rats. In Vivo. 2003; 17(6): 523-527.
33. Waterman IJ, Zammit VA. Differential effects of fenofibrate or simvastatin treatment of rats on hepatic microsomal overt and latent diacylglycerol acyltransferase activities. Diabetes. 2002; 51(6): 1708-1713.
34. Roglans N, Verd JC, Peris C, Alegret M, Vázquez M, Adzet T, Díaz C, Hernández G, Laguna JC, Sánchez RM. High doses of atrovastatin and simvastatin induce key enzymes involved in VLDL production. Lipids. 2002; 37(5): 445-454.
35. Ghirlanda G, Oradei A, Manto A, Lippa S, Uccioli L, Caputo S, Greco AV, Littarru GP. Evidence of plasma CoQ10-lowering effect by HMG-CoA reductase inhibitors: a double-blind, placebo-controlled study. J Clin Pharmacol. 1993; 33(3): 226-229.
36. Jasińska M, Owczarek J, Orszulak-Michalak D. The influence of simvastatin at high dose and diltiazem on myocardium in rabbits, the biochemical study. Acta Pol Pharm. 2006; 63(5): 386-390.
37. pispirigos K, Simopoulos K, Kouskoukis K, kounis N, Avramopoulos A. Evaluation of kidney and liver sub acute toxicity induced by Bezalip-Pravastatin-Lopid antihyperlipidaemic compounds in rats. Biochem Mol Biol Int. 1999; 47(3): 519-528.
38. Yamazaki H, Suzuki M, Aoki T, Morikawa S, Maejima T, Sato F, Sawanobori K, Kitahara M, Kodama T, Saito Y. Influence of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on ubiquinone levels in rat skeletal muscle and heart: relationship to cytotoxicity and inhibitory activity for cholesterol synthesis in human skeletal muscle cells. J Atheroscler Thromb. 2006; 13: 295-307.
39. Banaszewska B, Pawelczyk L, Spaczynski RZ, Dziura J, Duleba AJ. Effects of simvastatin and oral contraceptive agent on polycystic ovary syndrome: prospective, randomized, crossover Trial. The Journal of Clinical Endocrinology & Metabolism. 2007; 92(2): 456-461.
40. Santini SA, Carrosa C, Lulli P, Zuppi C, Tonolo GC, Musumeci S. Atrovastatin treatment does not affect gonadal and adrenal hormones in type 2 diabetes patients with mild to moderate hypercholesterolemia. J Atheroscler Thromb. 2003; 10: 160-164.
41. Smals AG, Weusten JJ, Benraad TJ, Kloppenbrog PW. The HMG-CoA reductase inhibitor simvastatin suppresses human testicular testosterone synthesis in vitro by a selective inhibitory effect on 17-ketosteroid-oxidoreductase enzyme activity. J Steroid Biochem Mol Biol. 1991; 38(4): 465-468.
42. Travert C, Fofana M, Carreau S, Le Goff D. Rat Leydig cells use apolipoprotein E depleted high density lipoprotein to regulate testosterone production. Mol Cell Biochem. 2000; 213(1-2): 51-59.
43. Bairey Merz CN, Olson MB, Johnson BD, Bittner V, Hodgson TK, Berga SL, Braunstein GD, Pepine CJ, Reis SE, Sopko G, Kelsev SF. Cholesterol-lowering medication, cholesterol level, and reproductive hormones in women; the women's ischemia syndrome evaluation (WISE). Am J Med. 2002; 113(9): 723-727.
44. Hou JW, Collins DC, Schleicher RI. Sources of cholesterol for testosterone biosynthesis in murine Leydig cell. Endocrinology. 1990; 127(5): 2047-2055.
45. Del Puppo M, Rauli S, Galli Kienle M. Inhibition of cholesterol synthesis and hepatic 3-hydroxy-3-methylglutaryl-CoA reductase in rats by simvastatin and pravastatin. Lipids. 1995; 30(11): 1057-1061.
46. Andreis PG, Cavallini L, Mazzocchi G, Nussdorfer GG. Effects of prolonged administration of lovastatin, an inhibitor of cholesterol synthesis, on the morphology and function of rat Leydig cells. Exp Clin Endocrinol. 1990; 96(1): 15-24.
47. Vlahcevic ZR, Pandak WM, Hylemon PB, Heuman DM. Role of newly synthesized cholesterol or its metabolites on the regulation of bile acid biosynthesis after short-term bilary diversion in the rat. Hepatology. 1993; 18(3): 660-668.